Alteplase associated Orolingual angioedema: A case report and literature review
Authors:
Open Access
- 30 December 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (52) , e32474
Abstract
Objective: Orolingual angioedema (OA) is a rare but life-threatening complication of intravenous thrombolysis using alteplase. Angioedema can be caused by almost any medication. Administration of recombinant tissue plasminogen activator causes atypical angioedema. This study aimed to investigate factors related to and treatment of OA after thrombolysis with alteplase. Case report: We describe the case of a 53-year-old man with a history of hypertension managed with enalapril, who presented with ischemic cerebrovascular stroke. Intravenous alteplase was administered, and within 54 minutes, the patient developed severe orolingual edema requiring emergent intubation. Subsequent imaging revealed an acute-to-subacute infarct in the left occipital lobe of the posterior cerebral artery. Results: The most common factor for increased risk of OA after recombinant tissue plasminogen activator was concomitant use of angiotensin-converting enzyme inhibitors (ACEI). Conclusion: Before intravenous thrombolytic therapy, patients should be asked if they have a history of allergies, are currently using ACEI, and try to avoid using ACEI antihypertensive drugs before and after thrombolytic therapy.Keywords
This publication has 11 references indexed in Scilit:
- Related factors with orolingual angioedema after intravenous alteplase in acute ischemic stroke: results from a single-center cohort and meta-analysisNeurological Sciences, 2021
- Unilateral orolingual angioedema in a patient with sarcoidosis after intravenous thrombolysis due to acute stroke without improvement after treatment with icatibantBMJ Case Reports, 2020
- Tissue Plasminogen Activator-Induced Angioedema Involving a Posterior Cerebral Artery Infarct: A Case PresentationAmerican Journal of Case Reports, 2020
- Intravenous Fibrinolysis for Central Retinal Artery OcclusionStroke, 2020
- Orolingual Angioedema After Tissue Plasminogen Activator Administration in Patients Taking Angiotensin-Converting Enzyme InhibitorsAdvanced Emergency Nursing Journal, 2019
- Angioedema in Stroke Patients With ThrombolysisStroke, 2019
- Increased fibrinolysis-induced bradykinin formation in hereditary angioedema confirmed using stored plasma and biotechnological inhibitorsBMC Research Notes, 2019
- Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular AccidentsCritical Care Research and Practice, 2018
- Impact of Bradykinin Generation During Thrombolysis in Ischemic StrokeFrontiers in Medicine, 2018
- Orolingual and abdominal angioedema post thrombolysis and thrombectomyNeurology, 2018